Literature DB >> 33718322

COVID-19: Rethinking the Lockdown Groupthink.

Ari R Joffe1,2.   

Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused the Coronavirus Disease 2019 (COVID-19) worldwide pandemic in 2020. In response, most countries in the world implemented lockdowns, restricting their population's movements, work, education, gatherings, and general activities in attempt to "flatten the curve" of COVID-19 cases. The public health goal of lockdowns was to save the population from COVID-19 cases and deaths, and to prevent overwhelming health care systems with COVID-19 patients. In this narrative review I explain why I changed my mind about supporting lockdowns. The initial modeling predictions induced fear and crowd-effects (i.e., groupthink). Over time, important information emerged relevant to the modeling, including the lower infection fatality rate (median 0.23%), clarification of high-risk groups (specifically, those 70 years of age and older), lower herd immunity thresholds (likely 20-40% population immunity), and the difficult exit strategies. In addition, information emerged on significant collateral damage due to the response to the pandemic, adversely affecting many millions of people with poverty, food insecurity, loneliness, unemployment, school closures, and interrupted healthcare. Raw numbers of COVID-19 cases and deaths were difficult to interpret, and may be tempered by information placing the number of COVID-19 deaths in proper context and perspective relative to background rates. Considering this information, a cost-benefit analysis of the response to COVID-19 finds that lockdowns are far more harmful to public health (at least 5-10 times so in terms of wellbeing years) than COVID-19 can be. Controversies and objections about the main points made are considered and addressed. Progress in the response to COVID-19 depends on considering the trade-offs discussed here that determine the wellbeing of populations. I close with some suggestions for moving forward, including focused protection of those truly at high risk, opening of schools, and building back better with a economy.
Copyright © 2021 Joffe.

Entities:  

Keywords:  COVID-19; cost-benefit analysis; groupthink; lockdowns; public health

Year:  2021        PMID: 33718322      PMCID: PMC7952324          DOI: 10.3389/fpubh.2021.625778

Source DB:  PubMed          Journal:  Front Public Health        ISSN: 2296-2565


  152 in total

Review 1.  "Herd immunity": a rough guide.

Authors:  Paul Fine; Ken Eames; David L Heymann
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

2.  Use of "normal" risk to improve understanding of dangers of covid-19.

Authors:  David Spiegelhalter
Journal:  BMJ       Date:  2020-09-09

Review 3.  Fifty Years of Research in ARDS. Long-Term Follow-up after Acute Respiratory Distress Syndrome. Insights for Managing Medical Complexity after Critical Illness.

Authors:  Margaret S Herridge
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

4.  A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.

Authors:  Tom Britton; Frank Ball; Pieter Trapman
Journal:  Science       Date:  2020-06-23       Impact factor: 47.728

5.  Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities.

Authors:  Elizabeth M White; Christopher M Santostefano; Richard A Feifer; Cyrus M Kosar; Carolyn Blackman; Stefan Gravenstein; Vincent Mor
Journal:  JAMA Intern Med       Date:  2020-12-01       Impact factor: 21.873

6.  Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic.

Authors:  Catherine K Ettman; Salma M Abdalla; Gregory H Cohen; Laura Sampson; Patrick M Vivier; Sandro Galea
Journal:  JAMA Netw Open       Date:  2020-09-01

7.  Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

Authors:  Davide F Robbiani; Christian Gaebler; Frauke Muecksch; Julio C C Lorenzi; Zijun Wang; Alice Cho; Marianna Agudelo; Christopher O Barnes; Anna Gazumyan; Shlomo Finkin; Thomas Hägglöf; Thiago Y Oliveira; Charlotte Viant; Arlene Hurley; Hans-Heinrich Hoffmann; Katrina G Millard; Rhonda G Kost; Melissa Cipolla; Kristie Gordon; Filippo Bianchini; Spencer T Chen; Victor Ramos; Roshni Patel; Juan Dizon; Irina Shimeliovich; Pilar Mendoza; Harald Hartweger; Lilian Nogueira; Maggi Pack; Jill Horowitz; Fabian Schmidt; Yiska Weisblum; Eleftherios Michailidis; Alison W Ashbrook; Eric Waltari; John E Pak; Kathryn E Huey-Tubman; Nicholas Koranda; Pauline R Hoffman; Anthony P West; Charles M Rice; Theodora Hatziioannou; Pamela J Bjorkman; Paul D Bieniasz; Marina Caskey; Michel C Nussenzweig
Journal:  Nature       Date:  2020-06-18       Impact factor: 69.504

8.  Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.

Authors:  Xin Wang; You Li; Katherine L O'Brien; Shabir A Madhi; Marc-Alain Widdowson; Peter Byass; Saad B Omer; Qalab Abbas; Asad Ali; Alberta Amu; Eduardo Azziz-Baumgartner; Quique Bassat; W Abdullah Brooks; Sandra S Chaves; Alexandria Chung; Cheryl Cohen; Marcela Echavarria; Rodrigo A Fasce; Angela Gentile; Aubree Gordon; Michelle Groome; Terho Heikkinen; Siddhivinayak Hirve; Jorge H Jara; Mark A Katz; Najwa Khuri-Bulos; Anand Krishnan; Oscar de Leon; Marilla G Lucero; John P McCracken; Ainara Mira-Iglesias; Jennifer C Moïsi; Patrick K Munywoki; Millogo Ourohiré; Fernando P Polack; Manveer Rahi; Zeba A Rasmussen; Barbara A Rath; Samir K Saha; Eric Af Simões; Viviana Sotomayor; Somsak Thamthitiwat; Florette K Treurnicht; Marylene Wamukoya; Lay-Myint Yoshida; Heather J Zar; Harry Campbell; Harish Nair
Journal:  Lancet Glob Health       Date:  2020-02-20       Impact factor: 26.763

9.  Genomic evidence for reinfection with SARS-CoV-2: a case study.

Authors:  Richard L Tillett; Joel R Sevinsky; Paul D Hartley; Heather Kerwin; Natalie Crawford; Andrew Gorzalski; Chris Laverdure; Subhash C Verma; Cyprian C Rossetto; David Jackson; Megan J Farrell; Stephanie Van Hooser; Mark Pandori
Journal:  Lancet Infect Dis       Date:  2020-10-12       Impact factor: 25.071

10.  Explaining the homogeneous diffusion of COVID-19 nonpharmaceutical interventions across heterogeneous countries.

Authors:  Abiel Sebhatu; Karl Wennberg; Stefan Arora-Jonsson; Staffan I Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-11       Impact factor: 12.779

View more
  22 in total

1.  Trust in Institutions, Not in Political Leaders, Determines Compliance in COVID-19 Prevention Measures within Societies across the Globe.

Authors:  Ryan P Badman; Ace X Wang; Martin Skrodzki; Heng-Chin Cho; David Aguilar-Lleyda; Naoko Shiono; Seng Bum Michael Yoo; Yen-Sheng Chiang; Rei Akaishi
Journal:  Behav Sci (Basel)       Date:  2022-05-30

Review 2.  Safety and Reverence: How Roman Catholic Liturgy Can Respond to the COVID-19 Pandemic.

Authors:  Sergey Budaev
Journal:  J Relig Health       Date:  2021-05-24

3.  Factors explaining the fear of being infected with COVID-19.

Authors:  Arcadio A Cerda; Leidy Y García
Journal:  Health Expect       Date:  2021-05-11       Impact factor: 3.318

Review 4.  Lessons from past pandemics: a systematic review of evidence-based, cost-effective interventions to suppress COVID-19.

Authors:  Carl-Etienne Juneau; Tomas Pueyo; Matt Bell; Genevieve Gee; Pablo Collazzo; Louise Potvin
Journal:  Syst Rev       Date:  2022-05-12

5.  The early impact of the global lockdown on post-secondary students and staff: A global, descriptive study.

Authors:  Behdin Nowrouzi-Kia; Leeza Osipenko; Parvin Eftekhar; Nasih Othman; Sultan Alotaibi; Alexandra M Schuster; Hae Sun Suh; Andrea Duncan
Journal:  SAGE Open Med       Date:  2022-01-25

Review 6.  The Endocannabinoid System as Prognostic Biomarker of the Obstructive Sleep Apnea Morbidity in COVID-19-Recovered Individuals.

Authors:  Eric Murillo-Rodríguez
Journal:  Sleep Vigil       Date:  2021-09-25

7.  The Acceptance of COVID-19 Vaccination Under Different Methods of Investigation: Based on Online and On-Site Surveys in China.

Authors:  Yun Lyu; Xiaozhen Lai; Xiaochen Ma; Lei Cao; Hong Lei; Jiahao Wang; Haijun Zhang; Rize Jing; Huangyufei Feng; Jia Guo; Li Li; Hai Fang
Journal:  Front Public Health       Date:  2021-11-25

Review 8.  The SARS-CoV-2 Pandemic in High Income Countries Such as Canada: A Better Way Forward Without Lockdowns.

Authors:  Ari R Joffe; David Redman
Journal:  Front Public Health       Date:  2021-11-22

9.  Antibiotic resistance during and beyond COVID-19.

Authors:  David M Livermore
Journal:  JAC Antimicrob Resist       Date:  2021-06-15

10.  A Citywide 'Virus Testing': Chinese Government's Response to Preventing and Controlling the Second Outbreak of SARS-CoV-2.

Authors:  Liting Zhou; Hans Nibshan Seesaghur; Nadeem Akhtar; Jason Boolakee; Cornelius B Pratt
Journal:  Front Public Health       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.